Amgen (AMGN) Tops Q2 EPS by 10c; Boosts FY16 Outlook
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $444.12 +0.29%
EPS Growth %: +2.7%
Financial Fact:
Product sales: 5.52B
Today's EPS Names:
VIVO, PMCB, PLCE, More
EPS Growth %: +2.7%
Financial Fact:
Product sales: 5.52B
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q2 EPS of $2.84, $0.10 better than the analyst estimate of $2.74. Revenue for the quarter came in at $5.69 billion versus the consensus estimate of $5.58 billion.
GUIDANCE:
Amgen sees FY2016 EPS of $11.10-$11.40. Amgen sees FY2016 revenue of $22.5-22.8 billion. The Street sees EPS of $11.18 and revenue of $22.57 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
- Concrete Pumping Holdings (BBCP) Tops Q3 EPS by 1c
- Guidewire Software (GWRE) Tops Q4 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
